Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
EMBO Molecular Medicine|April 9, 2014
HIF factors cooperate with PML-RARα to promote acute promyelocytic leukemia progression and relapseNadia Coltella, Stefano Percio, Roberta Valsecchi, et al.
Pharmaceuticals (Basel, Switzerland)|June 2, 2021
miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast CancerSilvia Martini, Valentina Zuco, Monica Tortoreto, et al.
Cancer Letters|May 10, 2024
Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesotheliomaMila Gugnoni, Eugenia Lorenzini, Federica Torricelli, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 13, 2019
Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer modelsMassimo Moro, Daniela Di Paolo, Massimo Milione, et al.
Cell Death & Disease|March 12, 2024
The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of actionCecilia Pandini, Giulia Pagani, Martina Tassinari, et al.
International Journal of Molecular Sciences|July 27, 2022
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate CancerValentina Doldi, Mara Lecchi, Silva Ljevar, et al.
Molecular Oncology|August 6, 2014
Senescent stroma promotes prostate cancer progression: the role of miR-210Maria Letizia Taddei, Lorenzo Cavallini, Giuseppina Comito, et al.
Cancer Letters|March 10, 2017
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axisRihan El Bezawy, Denis Cominetti, Nicola Fenderico, et al.
Cancer Research|February 27, 2009
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase CepsilonPaolo Gandellini, Marco Folini, Nicole Longoni, et al.
Oncotarget|May 8, 2015
Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivinMichelandrea De Cesare, Denis Cominetti, Valentina Doldi, et al.
Pageof 8